ScholarIQanswers from OpenAlex

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant

PaperCitations, authors & open-access status

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant have?

ScholarIQcitation count

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant has 31 citations in the OpenAlex counts ScholarIQ stores.

When was Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant published?

ScholarIQyear

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant has 2022 year in the ScholarIQ index.

What is the open-access status of Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant?

ScholarIQoa status

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant has green oa status in the ScholarIQ index.

What is the DOI of Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant?

ScholarIQdoi

The DOI for Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant is on the source record.

What is the OpenAlex record for Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant?

ScholarIQopenalex

The OpenAlex for Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial